UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 144

of 'Treatment of relapsed or refractory multiple myeloma'

144
TI
Efficacy of Daratumumab, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Among Patients with 1 to 3 Prior Lines of Therapy Based on Previous Treatment Exposure: Updated Analysis of Pollux (abstract 489)
AU
Moreau P,Kaufman JL,Sutherland HJ,Lalancette MlMagen H,Iida S
SO
Blood. 2016;
 
AD